166 related articles for article (PubMed ID: 34554113)
1. Challenges on the achievement of World Health Organization goals for HCV elimination in Italy: need for a Regional programmatic approach on screening and linkage to care. Commentary.
Kondili LA; Aghemo A; Andreoni M
Ann Ist Super Sanita; 2021; 57(3):201-204. PubMed ID: 34554113
[TBL] [Abstract][Full Text] [Related]
2. Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
Kondili LA; Blach S; Razavi H; Craxì A
Ann Ist Super Sanita; 2020; 56(3):325-329. PubMed ID: 32959798
[TBL] [Abstract][Full Text] [Related]
3. Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation.
Kondili LA; Aghemo A; Andreoni M; Galli M; Rossi A; Babudieri S; Nava F; Leonardi C; Mennini FS; Gardini I; Russo FP
Dig Liver Dis; 2022 Feb; 54(2):237-242. PubMed ID: 33926816
[TBL] [Abstract][Full Text] [Related]
4. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Kondili LA; Robbins S; Blach S; Gamkrelidze I; Zignego AL; Brunetto MR; Raimondo G; Taliani G; Iannone A; Russo FP; Santantonio TA; Zuin M; Chessa L; Blanc P; Puoti M; Vinci M; Erne EM; Strazzabosco M; Massari M; Lampertico P; Rumi MG; Federico A; Orlandini A; Ciancio A; Borgia G; Andreone P; Caporaso N; Persico M; Ieluzzi D; Madonia S; Gori A; Gasbarrini A; Coppola C; Brancaccio G; Andriulli A; Quaranta MG; Montilla S; Razavi H; Melazzini M; Vella S; Craxì A;
Liver Int; 2018 Dec; 38(12):2190-2198. PubMed ID: 29900654
[TBL] [Abstract][Full Text] [Related]
5. From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
Kondili LA; Craxì L; Nava F; Babudieri S; D'Ambrosio R; Marcellusi A; Mennini FS; Valle S; Russo P; Olimpieri PP; Andreoni M; Aghemo A
J Infect Dis; 2023 Sep; 228(Suppl 3):S211-S220. PubMed ID: 37703346
[TBL] [Abstract][Full Text] [Related]
6. Optimization of hepatitis C virus screening strategies by birth cohort in Italy.
Kondili LA; Gamkrelidze I; Blach S; Marcellusi A; Galli M; Petta S; Puoti M; Vella S; Razavi H; Craxi A; Mennini FS;
Liver Int; 2020 Jul; 40(7):1545-1555. PubMed ID: 32078234
[TBL] [Abstract][Full Text] [Related]
7. A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohort.
D'Ambrosio R; Piccinelli S; Beccalli B; Spinetti A; Puoti M; Fagiuoli S; Magni CF; Vavassori A; Sacchi P; Castaldi S; Bombardieri G; Farina C; Buoro S; Amorosi A; Corradin M; Cereda D; Lampertico P;
Liver Int; 2023 Dec; 43(12):2645-2656. PubMed ID: 37715524
[TBL] [Abstract][Full Text] [Related]
8. Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach.
Busschots D; Ho E; Blach S; Nevens F; Razavi H; Van Damme B; Vanwolleghem T; Robaeys G
BMC Infect Dis; 2022 Apr; 22(1):397. PubMed ID: 35459120
[TBL] [Abstract][Full Text] [Related]
9. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.
Sulkowski M; Cheng WH; Marx S; Sanchez Gonzalez Y; Strezewski J; Reau N
Adv Ther; 2021 Jan; 38(1):423-440. PubMed ID: 33145648
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
[TBL] [Abstract][Full Text] [Related]
11. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
12. Global timing of hepatitis C virus elimination in high-income countries.
Razavi H; Sanchez Gonzalez Y; Yuen C; Cornberg M
Liver Int; 2020 Mar; 40(3):522-529. PubMed ID: 31815353
[TBL] [Abstract][Full Text] [Related]
13. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
[TBL] [Abstract][Full Text] [Related]
14. Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
[TBL] [Abstract][Full Text] [Related]
15. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
16. Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.
D'Ambrosio R; Rizzardini G; Puoti M; Fagiuoli S; Anolli MP; Gabiati C; D'Amico F; Pasulo L; Restelli U; Colombo M; Lampertico P
Liver Int; 2022 May; 42(5):1012-1016. PubMed ID: 35220667
[TBL] [Abstract][Full Text] [Related]
17. A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.
Kondili LA; Andreoni M; Alberti A; Lobello S; Babudieri S; De Michina A; Merolla R; Marrocco W; Craxì A
BMC Infect Dis; 2022 Jan; 22(1):58. PubMed ID: 35038987
[TBL] [Abstract][Full Text] [Related]
18. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.
Rosato V; Kondili LA; Nevola R; Perillo P; Mastrocinque D; Aghemo A; Claar E
Viruses; 2022 May; 14(5):. PubMed ID: 35632837
[No Abstract] [Full Text] [Related]
19. A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project.
Dröse S; Øvrehus ALH; Holm DK; Madsen LW; Mössner BK; Søholm J; Hansen JF; Røge BT; Christensen PB
BMC Infect Dis; 2022 Mar; 22(1):202. PubMed ID: 35232372
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
